NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
NERVGEN PHARMA CORP.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026
$1.54−0.05 (-3.14%)
Close on Oct 19, 2026
Community
Notes and questions about Nervgen Pharma from other investors
No posts about NGEN yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.